Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

United Therapeutics

Tracked across 4 events · 26 articles · First seen Jan 25, 2025 · Last active Jul 02, 2026

Sentiment
35
Attention
4
Events
4
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: United Therapeutics initiated a Phase 2 clinical trial for its EGCg-based investigational therapy for precancerous cervical lesions, which could significantly advance its product pipeline and market position.
May 19, 2026 · 7 articles
4 70
Business
Impact: United Therapeutics acquired Thymmune Therapeutics, Inc. for $140 million in cash, with potential earn-out payments up to $160 million. This acquisition expands United Therapeutics' capabilities in regenerative medicine and organ alternatives, aligning with its mission to address rare diseases and organ supply.
Jul 02, 2026 · 7 articles
2 0
Business
Impact: United Therapeutics was one of the presenting companies at the Life Sciences Virtual Investor Forum.
Jun 26, 2026 · 6 articles
4 0
Business
Apr 08, 2026 · 6 articles
3D Systems development partner United Therapeutics United Therapeutics partners with 3D Systems to leverage their advanced bioprint
3D Systems technology partner United Therapeutics 3D Systems acts as a critical technology partner to United Therapeutics, supplyi
ERGEN INTELLIGENCE
Track United Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.